An announcement from Mineralys Therapeutics, Inc. ( ($MLYS) ) is now available. On January 6, 2026, Mineralys Therapeutics provided a corporate ...

I had reservations about these tools and how they might affect me as a musician, but I was also intrigued by the ...

Legacy firms can’t advise AI reinvention without reinventing themselves. Real change means shifting from labor-based models ...

Allergen Alert says it is transforming our relationship with food, making it more transparent, more responsible, more ...

Singapore's growth as a global digital and LNG hub is colliding with its physical and energetic capacity, forcing a ...

Web3 SaaS platform Roundtable signed a 10-year exclusive agreement to operate The Hockey News’ media network, commerce ...

Amanpal Dhupar, Head of Retail at Tredence is an experienced retail analytics and AI leader with over a decade of expertise ...

By involving children as active participants in their own anti-bullying efforts, schools can foster empathy, critical ...

On Wednesday, AstroNova (NASDAQ:ALOT) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below.

When AI can explain its why, not just its what, hospitals can have greater success in adopting these tools at scale.

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...